PortfoliosLab logoPortfoliosLab logo
AUTL vs. SPMO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

AUTL vs. SPMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Autolus Therapeutics plc (AUTL) and Invesco S&P 500 Momentum ETF (SPMO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AUTL achieves a -18.59% return, which is significantly lower than SPMO's 30.35% return.


AUTL

1D
-7.43%
1M
3.18%
YTD
-18.59%
6M
9.46%
1Y
-21.74%
3Y*
-17.64%
5Y*
-23.91%
10Y*

SPMO

1D
0.50%
1M
15.36%
YTD
30.35%
6M
30.51%
1Y
46.00%
3Y*
43.04%
5Y*
24.29%
10Y*
20.95%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AUTL vs. SPMO - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
AUTL
Autolus Therapeutics plc
-18.59%-15.32%-63.51%238.95%-63.39%-41.95%-32.27%-59.81%31.36%
SPMO
Invesco S&P 500 Momentum ETF
30.35%26.58%45.82%17.56%-10.45%22.64%28.25%25.93%-10.03%

Correlation

The correlation between AUTL and SPMO is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Jun 25, 2018

0.22

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AUTL vs. SPMO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AUTL
AUTL Risk / Return Rank: 3030
Overall Rank
AUTL Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
AUTL Sortino Ratio Rank: 3232
Sortino Ratio Rank
AUTL Omega Ratio Rank: 3232
Omega Ratio Rank
AUTL Calmar Ratio Rank: 2727
Calmar Ratio Rank
AUTL Martin Ratio Rank: 3131
Martin Ratio Rank

SPMO
SPMO Risk / Return Rank: 7575
Overall Rank
SPMO Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
SPMO Sortino Ratio Rank: 7777
Sortino Ratio Rank
SPMO Omega Ratio Rank: 7777
Omega Ratio Rank
SPMO Calmar Ratio Rank: 7171
Calmar Ratio Rank
SPMO Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AUTL vs. SPMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Autolus Therapeutics plc (AUTL) and Invesco S&P 500 Momentum ETF (SPMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AUTLSPMODifference
Sharpe ratioReturn per unit of total volatility

-2.91

Sortino ratioReturn per unit of downside risk

-3.47

Omega ratioGain probability vs. loss probability

1.01

1.47

-0.46

Calmar ratioReturn relative to maximum drawdown

-0.40

3.64

-4.04

Martin ratioReturn relative to average drawdown

-0.56

14.17

-14.73

AUTL vs. SPMO - Sharpe Ratio Comparison

The current AUTL Sharpe Ratio is -0.29, which is lower than the SPMO Sharpe Ratio of 2.62. The chart below compares the historical Sharpe Ratios of AUTL and SPMO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AUTLSPMODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.29

2.62

-2.91

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.31

1.27

-1.57

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

1.03

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.36

1.01

-1.37

Drawdowns

AUTL vs. SPMO - Drawdown Comparison

The maximum AUTL drawdown since its inception was -97.63%, which is greater than SPMO's maximum drawdown of -30.95%. Use the drawdown chart below to compare losses from any high point for AUTL and SPMO.


Loading charts...

Drawdown Indicators


AUTLSPMODifference

Max Drawdown

Largest peak-to-trough decline

-97.63%

-30.95%

-66.68%

Max Drawdown (1Y)

Largest decline over 1 year

-54.85%

-12.70%

-42.15%

Max Drawdown (3Y)

Largest decline over 3 years

-84.36%

-20.13%

-64.23%

Max Drawdown (5Y)

Largest decline over 5 years

-85.68%

-22.74%

-62.94%

Max Drawdown (10Y)

Largest decline over 10 years

-30.95%

Current Drawdown

Current decline from peak

-96.63%

0.00%

-96.63%

Average Drawdown

Average peak-to-trough decline

-81.25%

-4.60%

-76.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

38.75%

3.26%

+35.49%

Volatility

AUTL vs. SPMO - Volatility Comparison

Autolus Therapeutics plc (AUTL) has a higher volatility of 23.55% compared to Invesco S&P 500 Momentum ETF (SPMO) at 7.35%. This indicates that AUTL's price experiences larger fluctuations and is considered to be riskier than SPMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AUTLSPMODifference

Volatility (1M)

Calculated over the trailing 1-month period

23.55%

7.35%

+16.20%

Volatility (6M)

Calculated over the trailing 6-month period

52.52%

14.39%

+38.13%

Volatility (1Y)

Calculated over the trailing 1-year period

75.72%

17.64%

+58.08%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

77.73%

19.30%

+58.43%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.84%

20.31%

+60.53%

Dividends

AUTL vs. SPMO - Dividend Comparison

AUTL has not paid dividends to shareholders, while SPMO's dividend yield for the trailing twelve months is around 0.65%.


PositionTTM20252024202320222021202020192018201720162015
AUTL
Autolus Therapeutics plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPMO
Invesco S&P 500 Momentum ETF
0.65%0.73%0.48%1.63%1.66%0.52%1.27%1.39%1.05%0.77%1.94%0.36%

Frequently Asked Questions


AUTL and SPMO have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AUTL has higher volatility (23.55%) compared to SPMO (7.35%). In terms of maximum drawdown, AUTL dropped -97.63% vs SPMO's -30.95%.

SPMO currently has the higher Sharpe Ratio (2.62 vs -0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AUTL and SPMO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer